Physician profile
Scott A Addison
NPI 1548236888
$1,556.95
in general payments reported to CMS, 2019-2025
23 companies · $37.70 in 2025
The $37.70 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,223 · 2020: $245 · 2022: $18.22 · 2023: $17.94 · 2024: $15.14 · 2025: $37.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $37.70 · Food and Beverage: $33.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $37.70 |
| Food and Beverage | $33.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $284.29 | 2019-2024 | Ozempic, Rybelsus |
| Pfizer INC. | $225.07 | 2019-2020 | |
| Amgen INC. | $221.44 | 2019-2020 | |
| Amarin Pharma, INC. | $174.22 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $108.32 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.40 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $60.00 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $53.48 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $51.06 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $34.61 | 2019 | |
| Allergan, INC. | $29.29 | 2019 | |
| Mylan Specialty L.P. | $28.15 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $27.63 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $23.30 | 2019 | |
| Astellas Pharma US INC | $22.17 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.95 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $19.77 | 2019 | |
| Abbvie INC. | $18.22 | 2022 | |
| Sunovion Pharmaceuticals INC. | $16.68 | 2019 | |
| Medtronic Vascular, INC. | $15.89 | 2019 | |
| Ironshore Pharmaceuticals INC. | $13.25 | 2019 | |
| Lilly USA, LLC | $12.17 | 2019 | |
| Neos Therapeutics, LP | $11.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Addison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.